Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel

NCT01643031 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus
Coronary Disease

Interventions

DRUG: Ticagrelor
DRUG: Continued clopidogrel

Sponsor

Rabin Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]